Levitsky Hyam Insider Trades

Insider Trading History

Track insider trading activity for Levitsky Hyam. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Replimune Group
Replimune Group REPL
Director
Holding Value $365k 32,000 shares
Last Trade
Apr 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$247k 32,000 shares
$7.73
$11.42
Century Therapeutics
Century Therapeutics IPSC
President Of R&d
Holding Value $352k 146,000 shares
Last Trade
Mar 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$777k 146,000 shares
$5.32
$2.41
Century Therapeutics
Century Therapeutics IPSC
President Of R&d
Holding Value $316k 131,250 shares
Last Trade
Apr 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$382k 131,250 shares
$2.91
$2.41
Century Therapeutics
Century Therapeutics IPSC
President Of R&d
Holding Value $0 0 shares
Last Trade
Apr 12, 2023 Sale
$99.3k 34,116 shares
$2.91
$2.41
Replimune Group
Replimune Group REPL
Director
Holding Value $288k 25,200 shares
Last Trade
Apr 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 25,200 shares
$17.66
$11.42
Replimune Group
Replimune Group REPL
Director
Holding Value $188k 16,500 shares
Last Trade
Apr 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$603k 33,000 shares
$18.26
$11.42
Century Therapeutics
Century Therapeutics IPSC
President Of R&d
Holding Value $253k 105,000 shares
Last Trade
Jan 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.38M 105,000 shares
$13.15
$2.41
Century Therapeutics
Century Therapeutics IPSC
President Of R&d
Holding Value $0 0 shares
Last Trade
Jun 17, 2021 Sale
No data
No data
$2.41
Replimune Group
Replimune Group REPL
Director
Holding Value $188k 16,500 shares
Last Trade
Apr 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$521k 16,500 shares
$31.58
$11.42
Replimune Group
Replimune Group REPL
Director
Holding Value $188k 16,500 shares
Last Trade
Apr 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$161k 16,500 shares
$9.78
$11.42
Replimune Group
Replimune Group REPL
Director
Holding Value $154k 13,500 shares
Last Trade
Apr 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$209k 13,500 shares
$15.50
$11.42
Replimune Group
Replimune Group REPL
Director
Holding Value $308k 27,000 shares
Last Trade
Jul 24, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405k 27,000 shares
$15.00
$11.42
Agenus
Agenus AGEN
Director
Holding Value $389k 126,632 shares
Last Trade
Jul 01, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$571k 5,989 shares
$95.35
$3.07
Agenus
Agenus AGEN
Director
Holding Value $353k 115,000 shares
Last Trade
Jun 16, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.43M 15,000 shares
$95.35
$3.07
Agenus
Agenus AGEN
Director
Holding Value $324k 105,643 shares
Last Trade
Apr 01, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$599k 5,643 shares
$106.08
$3.07
Agenus
Agenus AGEN
Director
Holding Value $307k 100,000 shares
Last Trade
Jun 14, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.68M 15,000 shares
$111.83
$3.07
Agenus
Agenus AGEN
Director
Holding Value $261k 85,000 shares
Last Trade
May 13, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.19M 15,000 shares
$145.97
$3.07
Agenus
Agenus AGEN
Director
Holding Value $215k 70,000 shares
Last Trade
Jun 11, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.78M 15,000 shares
$251.92
$3.07
Agenus
Agenus AGEN
Director
Holding Value $169k 55,000 shares
Last Trade
Feb 27, 2009 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$724k 15,376 shares
$47.09
$3.07
Agenus
Agenus AGEN
Director
Holding Value $47.2k 15,376 shares
Last Trade
Feb 27, 2009 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$724k 15,376 shares
$47.09
$3.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up